Clinical Trial Update: Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of dupilumab on mucociliary clearance in adults with moderate-to-severe asthma; study status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Sally E. Wenzel MD | Conditions: Asthma | Phase 4 | Status: RECRUITING